SCHEMBL19936623

SCHEMBL19936623

CCN/C=C1/C=C(NC(=O)OCc2sc(-c3ccc(C)cc3C)nc2C)C=CC1=N

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
LMNA P02545 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
FFAR1 O14842 2/20 0.31
PPARD Q03181 2/20 0.31
NLRP3 Q96P20 1/20 0.31
POLB P06746 1/20 0.30
TP53 P04637 1/20 0.30
GLA P06280 1/20 0.30
HSP90AB1 P08238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19936521 0.92 MAPT (0.33) MAPTSMN1; SMN2KDM4EMEN1ALDH1A1
SCHEMBL19936575 0.85 FFAR1 (0.34) MAPTLMNAFFAR1PPARDTP53
SCHEMBL19936419 0.76 ALDH1A1 (0.33) SMN1; SMN2KDM4EMEN1ALDH1A1KMT2A
SCHEMBL14805011 0.74 MAPT (0.46) MAPTSMN1; SMN2KDM4ELMNAPOLB
SCHEMBL14800580 0.70 AGPAT2 (0.45) MAPTSMN1; SMN2MEN1KMT2ALMNA
SCHEMBL3436487 0.68 NPC1 (0.43) MAPTSMN1; SMN2KDM4EMEN1ALDH1A1
SCHEMBL19936587 0.68 SMN1; SMN2 (0.34) MAPTSMN1; SMN2NLRP3POLB
SCHEMBL14805030 0.68 GAA (0.49) MAPTKDM4EMEN1ALDH1A1KMT2A
SCHEMBL14805055 0.68 NOTUM (0.41) MAPTSMN1; SMN2POLBTP53
SCHEMBL14805063 0.68 NOTUM (0.41) MAPTSMN1; SMN2MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2594555-B1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR ASKA PHARM CO LTD (JP) 2018-03-07 EP disclosed